About Elucidata
Elucidata is a company based in San Francisco (United States) founded in 2015 by Richard ichard Kibbey, Swetabh Pathak, and Abhishek Kumar Jha. It operates as a AI-as-a-Service, Managed Services, and HealthTech. Elucidata has raised $22.7 million across 4 funding rounds from investors including IvyCap Ventures, Eight Roads Ventures and F-Prime Capital. The company has 132 employees as of June 22, 2024. Elucidata offers products and services including Polly, Data Concierge, and Bioinformatics Pipeline Building. Elucidata operates in a competitive market with competitors including IQVIA, Komodo Health, Clarify, Dental Intel and AVIA, among others.
- Headquarter San Francisco, United States
- Employees 132 as on 22 Jun, 2024
- Founders Richard ichard Kibbey, Swetabh Pathak, Abhishek Kumar Jha
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elucidata Data Consulting Private Limited
- Date of Incorporation 22 Mar, 2016
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$2.3 M (USD)107.69as on Mar 31, 2022
-
Net Profit
$115.9 K (USD)778.33as on Mar 31, 2022
-
EBITDA
$201.27 K (USD)280.42as on Mar 31, 2022
-
Total Equity Funding
$22.7 M (USD)
in 4 rounds
-
Latest Funding Round
$16 M (USD), Series A
Sep 27, 2022
-
Investors
IvyCap Ventures
& 3 more
-
Employee Count
132
as on Jun 22, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elucidata
Elucidata offers a comprehensive portfolio of products and services, including Polly, Data Concierge, and Bioinformatics Pipeline Building.
AI platform harmonizes biomedical data for research.
Noise is filtered from scientific literature data.
Custom pipelines are built for data analysis.
People of Elucidata
Unlock access to complete
Unlock access to complete
Funding Insights of Elucidata
Elucidata has successfully raised a total of $22.7M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $16 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elucidata
Elucidata has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include IvyCap Ventures, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked | |
|
Venture capital investments in startups from leading Indian institutions across various sectors.
|
Locked | Locked | Locked |
Investor details for Elucidata
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elucidata
Investment portfolio details for Elucidata
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elucidata
Detailed financials for Elucidata
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elucidata Comparisons
Peer comparison for Elucidata
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elucidata
Elucidata operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IQVIA, Komodo Health, Clarify, Dental Intel and AVIA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Data-driven insights are delivered to healthcare via AI platforms.
|
|
| Locked | Locked | Locked |
Marketing and business consulting services are provided by Clarify.
|
|
| Locked | Locked | Locked |
Dental intelligence is delivered via SaaS platform for performance analytics.
|
|
| Locked | Locked | Locked |
Digital platform for healthcare management and networking is offered.
|
|
| Locked | Locked | Locked |
Platform for hospitals to manage staff recruitments and replacements
|
Detailed competitors of Elucidata
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elucidata
Complete news archive for Elucidata
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elucidata
Elucidata was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Elucidata is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Abhishek Kumar Jha is the current CEO of Elucidata. They have also founded this company.
Elucidata is a funded company, having raised a total of $22.7M across 4 funding rounds to date.
As of Jun 22, 2024, the latest employee count at Elucidata is 132.
Annual revenue of Elucidata is $2.3M as on Mar 31, 2022.
Elucidata is engaged in transforming drug discovery through AI-powered data solutions. Biomedical data is harmonized and integrated using the Polly platform, which supports multi-modal data types like omics, imaging, and clinical data. Solutions are provided for target identification, biomarker discovery, and patient stratification across sectors such as biopharma, precision medicine, and translational research. Scalable cloud infrastructure and secure data handling are ensured to accelerate RD outcomes and drive impactful health innovations globally.
Elucidata's top competitors include IQVIA, Komodo Health and AVIA.
Elucidata offers Polly, Data Concierge, and Bioinformatics Pipeline Building.
Elucidata has 4 investors. Key investors include IvyCap Ventures, Eight Roads Ventures, F-Prime Capital, and Hyperplane.
The valuation of Elucidata is $18.3M as of Dec 2020.